Odyssey Therapeutics Inc (ODTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Sales | 0 | 0 | 1,918 |
| Gross Profit | N/A | N/A | 1,918 |
| Operating Expenses | 39,780 | 0 | 41,078 |
| Operating Income | -39,780 | N/A | -39,160 |
| Interest Expense | 10 | 0 | 2 |
| Other Income | 1,591 | 0 | 867 |
| Pre-tax Income | -38,199 | 0 | -38,295 |
| Income Tax | 63 | N/A | 140 |
| Net Income Continuous | -38,262 | N/A | -38,435 |
| Net Income | $-38,262 | $N/A | $-38,435 |
| EPS Basic Total Ops | -6.77 | N/A | -39.37 |
| EPS Basic Continuous Ops | -6.77 | N/A | -39.37 |
| EPS Diluted Total Ops | -6.77 | N/A | -39.37 |
| EPS Diluted Continuous Ops | -6.77 | N/A | -39.37 |
| EPS Diluted Before Non-Recurring Items | -6.77 | N/A | N/A |
| EBITDA(a) | $-38,609 | $N/A | $-37,861 |